- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 138
Daily deal net: February 18, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Feb 18, 2020OMass compiles $53.9m series A
University of Oxford-founded OMass Therapeutics has extended its series A round to progress a pipeline targeting immunological and genetic disorders.
Feb 18, 2020Amber rams through $28m series A
Paradigm co-led the latest round for crypto trading services provider Amber, with Coinbase and Blockchain.com also investing.
Feb 18, 2020CloudCath cleans up with series A funding
Stanford-StartX Fund contributed to a $12m round for catheter monitor developer CloudCath, whose clinical advisory chairman hails from Stanford University.
Feb 17, 2020Corporate venturing deal net: 10-14 February 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds
Feb 14, 2020Grabwheels rolls on with $30m from Kymco
Grab's electric scooter rental service has picked up a series A investment from motorcycle producer and new strategic partner Kymco.
Feb 14, 2020Oxford VR boxes in $13m series A
VR mental health software developer Oxford VR secured the return of both OUI and OSI to increase its funding to more than $17m.
Feb 13, 2020Daily deal net: February 12, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Feb 12, 2020Baseconnect links to corporates in series A round
Yahoo Japan, Uzabase, Orico and Nihon Unisys all chipped into a $16.4m round for the corporate information database operator, which will spend the cash on technology development and marketing.
Feb 10, 2020Sonoma sends for Lyell in $40m series A
Sonoma Biotherapeutics has emerged from stealth with $40m to develop regulatory T-cell therapies for autoimmune and degenerative diseases.
Feb 10, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


